UroLift System by Teleflex Interventional Urology

medical devices

About

Teleflex Incorporated is a global medical technology company that focuses on improving patient health through innovative medical devices. The UroLift System, developed by its Interventional Urology Business Unit, is designed to treat benign prostatic hyperplasia (BPH), a common condition in men that causes urinary issues due to an enlarged prostate. The UroLift System is a minimally invasive solution that provides permanent relief from prostate obstruction without the need for cutting or removing tissue. It is delivered through a transurethral outpatient procedure, placing small implants to retract obstructing prostatic lobes and open the urethra. The recently launched UroLift 2 System with Advanced Tissue Control expands treatment options for a wider range of prostate anatomies. Teleflex markets the UroLift System primarily to urologists and healthcare providers, making it available in various international markets.

Technologies

CSC Corporate Domains Outlook Microsoft Office 365 React The Trade Desk

Keywords

urology bph medical device enlarged prostate minimally invasive healthcare medical equipment manufacturing permanent implants outpatient urology surgical alternative clinical trial bph permanent prostate implants urinary flow restoration rapid recovery patient safety bph prostate volume treatment prostate anatomy urolift system medical devices preservation of sexual function patient recovery head-to-head bph study services minimally invasive urology prostate treatment symptom relief permanent prostate device patient safety preserves sexual function urology device innovation

Location

4473 Willow Road, Pleasanton, California, United States, 94588

Related Companies

Companies in the same industry